SARS-CoV-2 mRNA-vaccine candidate; COReNAPCIN®, induces robust humoral and cellular immunity in mice and non-human primates

This article has been Reviewed by the following groups

Read the full article

Abstract

At the forefront of biopharmaceutical industry, the messenger RNA (mRNA) technology offers a flexible and scalable platform to address the urgent need for world-wide immunization in pandemic situations. This strategic powerful platform has recently been used to immunize millions of people proving both of safety and highest level of clinical efficacy against infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Here we provide preclinical report of COReNAPCIN ® ; a vaccine candidate against SARS-CoV-2 infection. COReNAPCIN ® is a nucleoside modified mRNA-based vaccine formulated in lipid nanoparticles (LNPs) for encoding the full-length prefusion stabilized SARS-CoV-2 spike glycoprotein on the cell surface. Vaccination of C57BL/6 and BALB/c mice and rhesus macaque with COReNAPCIN ® induced strong humoral responses with high titers of virus-binding and neutralizing antibodies. Upon vaccination, a robust SARS-CoV-2 specific cellular immunity was also observed in both mice and non-human primate models. Additionally, vaccination protected rhesus macaques from symptomatic SARS-CoV-2 infection and pathological damage to the lung upon challenging the animals with high viral loads of up to 2 × 10 8 live viral particles. Overall, our data provide supporting evidence for COReNAPCIN ® as a potent vaccine candidate against SARS-CoV-2 infection for clinical studies.

Article activity feed

  1. SciScore for 10.1101/2022.03.05.483092: (What is this?)

    Please note, not all rigor criteria are appropriate for all manuscripts.

    Table 1: Rigor

    Ethicsnot detected.
    Sex as a biological variableTotal number of 80 BALB/c mice in four groups (15 females and 5 males per group), and 48 C57BL/6 mice in four groups (12 females in each group), were injected intramuscularly (IM) with either phosphate-buffered saline (PBS) or 0.05, 0.5, or 3 μg mRNA-LNP at days 0 and 21.
    Randomizationnot detected.
    Blindingnot detected.
    Power Analysisnot detected.
    Cell Line Authenticationnot detected.

    Table 2: Resources

    Antibodies
    SentencesResources
    After 2 hrs blocking in a buffer containing 5% fat-free dried milk and 0.5% Tween-20, the membrane was incubated with anti-SARS-CoV-2 spike polyclonal antibody (Sino biological) or anti-β-actin polyclonal antibody (Abcam) overnight at 4°C.
    anti-SARS-CoV-2
    suggested: None
    anti-β-actin
    suggested: None
    Flow cytometry: In order to analyze transfected cells for cell surface expression of S protein, 2×105 cells of each of transfected and untransfected cells stained with SARS-CoV-2 Spike antibody (SinoBiological) and Anti-human IgG FITC (Sigma-Aldrich®).
    Anti-human IgG
    suggested: None
    After incubation with detection antibody (7-B6-ALP) and subsequent washing, 100 μl substrate solution (BCIP/NBT-plus) added to each well.
    7-B6-ALP
    suggested: None
    Experimental Models: Cell Lines
    SentencesResources
    In vitro characterization of mRNA-LNP: 4-4-1 Cell transfection: Primarily, HEK 293T cells were seeded into a 12-well cell culture plate, 2×105 cells per well in HG-DMEM medium (Biowest).
    HEK 293T
    suggested: None
    After 60 min incubation at 37°C, the virus-serum mixture was added to 96 well-plate previously seeded with 1.5 × 104 Vero cells per well (performed in triplicate).
    Vero
    suggested: CLS Cat# 605372/p622_VERO, RRID:CVCL_0059)
    Experimental Models: Organisms/Strains
    SentencesResources
    Animal models and immunization: Immunogenicity of COReNAPCIN® vaccine candidate was assessed in mice (BALB/c and C57BL/6) and rhesus macaques.
    BALB/c
    suggested: None
    Mice immunization: BALB/c and C57BL/6 mice (16-18 g, 4-6 weeks old) were purchased from the Pasteur Institute of Iran.
    C57BL/6
    suggested: None
    Recombinant DNA
    SentencesResources
    This DNA sequence was cloned into ReNAP-IVT1 plasmid in between special 5’-UTR and 3’-UTR-polyA tail, for transcribing the mRNA under the control of a T7 promoter.
    ReNAP-IVT1
    suggested: None
    Spike pseudotyped lentivirus, produced by the co-transfection of plex307-egfp, pCMV3-spike (Wuhan-D614G), and pspax2 with Lipofectamine 3000 (Thermo)
    pCMV3-spike
    suggested: None
    Software and Algorithms
    SentencesResources
    IC50 was calculated using the percentage of GFP positive cell versus log (dilution factor) in GraphPad Prism V8. 4.9
    GraphPad Prism
    suggested: (GraphPad Prism, RRID:SCR_002798)
    After 20 minutes incubation and washing with permeabilization and staining buffer (Biolegend), cells were acquired on BD FACS Lyrics and analyzed by Flowjo V10 (BD Biosciences). 4.12.
    Flowjo
    suggested: (FlowJo, RRID:SCR_008520)
    Statistical analysis: Graph Pad V8 Prism was used to illustrates the figures and analyze the results statistically.
    Prism
    suggested: (PRISM, RRID:SCR_005375)

    Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).


    Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.

    Results from TrialIdentifier: No clinical trial numbers were referenced.


    Results from Barzooka: We did not find any issues relating to the usage of bar graphs.


    Results from JetFighter: We did not find any issues relating to colormaps.


    Results from rtransparent:
    • Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
    • Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
    • No protocol registration statement was detected.

    Results from scite Reference Check: We found no unreliable references.


    About SciScore

    SciScore is an automated tool that is designed to assist expert reviewers by finding and presenting formulaic information scattered throughout a paper in a standard, easy to digest format. SciScore checks for the presence and correctness of RRIDs (research resource identifiers), and for rigor criteria such as sex and investigator blinding. For details on the theoretical underpinning of rigor criteria and the tools shown here, including references cited, please follow this link.